Medical Device News Magazine

Augmedix Announces an Updated Version of Its proprietary Notebuilder Tool

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Notebuilder is the key natural language processing (NLP) component of the Augmedix technology platform, enabling virtual scribes to create best practice clinical notes powered by intelligent automation.

Augmedix notes the updated Notebuilder now includes all three major sections of the note (History of Present Illness, Physical Exam and Assessment & Plan), external medication datasets and customized note content based upon clinician preferences.

Notebuilder utilizes identifiers such as specialty, visit type, complaints, symptoms and frequency alongside scribe specific inputs, to automatically generate and organize clinically relevant structured medical notes which can then be inserted into the patient’s electronic health record (EHR). Selection options are dynamically filtered as the virtual scribe makes entries such that the most relevant selections are displayed. This intelligent automation approach achieves cost-effective, accurate, and timely documentation.

“We often hear how artificial intelligence (AI) will replace the human workforce. We have found that when it comes to capturing clinical conversations, which are essentially unstructured data, the most effective solution available today is the use of a hybrid model: blending both AI and human intellect,” said Manny Krakaris, Chief Executive Officer at Augmedix. “We are thrilled to bring our enhanced Notebuilder solution to our global scribe workforce. Based on the experience of our scribes already using the tool across the globe, we know that we are delivering cost-effective, timely and accurate clinical documentation to our customers.”

Notebuilder allows customizations based upon specialty, clinic or individual clinician preferences. Specific clinician preference templates can be saved within the tool and used by the virtual scribe as needed. Notebuilder provides virtual scribes with access to medical data sets such as a medication database with dosages, frequency and related side effects.

“Technology is built to help clinicians, but we know that it often has the opposite effect, slowing down processes and impairing operational efficiencies,” said Dr. Davin Lundquist, Chief Medical Officer at Augmedix. “Notebuilder empowers clinicians to care for their patients while the visit is simultaneously being documented in real-time by a specialty trained scribe. Notebuilder enables our clinicians to have natural, ambient conversations with their patients unlike other solutions which force more rigidity and behavior change, and in many cases, outright dictation. Technology is best when it enhances clinician workflow—we solve this challenge by combining AI and the knowledge of clinicians to more efficiently complete documentation.”

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”